Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

syngeneic bone marrow transplantation

Known as: bone marrow transplantation, syngeneic, transplantation, syngeneic bone marrow 
A procedure in which a person receives bone marrow donated by his or her healthy identical twin.
National Institutes of Health

Related topics

Related topics

1 relation
Bone Marrow Transplantation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis.
The demand for treatment strategies for damaged musculoskeletal tissue is continuously growing, especially with the increasing… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
The duration of immunodeficiency following marrow transplantation is not known. Questionnaires were used to study the infection… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1998
1998
Effect of disease stage on clinical outcome after syngeneic bone marrow transplantation for relapsing experimental autoimmune encephalomyelitis.
Relapsing experimental autoimmune encephalomyelitis (R-EAE) is an immune-mediated demyelinating central nervous system (CNS… Expand
Is this relevant?
1998
1998
Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice.
Recombinant human growth hormone (rhGH) was administered to mice after syngeneic bone marrow transplantation (BMT) to determine… Expand
Is this relevant?
1996
1996
Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice.
Successful outcome of autologous bone marrow transplantation (BMT) is severely handicapped by susceptibility to infection and by… Expand
Is this relevant?
1995
1995
Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
MPS VII mice are deficient in beta-glucuronidase and share many clinical, biochemical, and pathologic characteristics with human… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
1992
1992
Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
Experimental autoimmune encephalomyelitis (EAE) is an inducible autoimmune disease widely used as a model of the acute/relapsing… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation.
The gusmps/gusmps mouse has no beta-glucuronidase activity and develops murine mucopolysaccharidosis type VII (MPS VII). The… Expand
Is this relevant?
Highly Cited
1987
Highly Cited
1987
Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation.
Graft-vs-host disease (GVHD) is a frequent complication of allogeneic bone marrow transplantation but has been infrequently… Expand
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Development of graft-vs.-host disease-like syndrome in cyclosporine- treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti…
Lethally irradiated rats reconstituted with syngeneic bone marrow and treated with cyclosporine (CsA) for 40 d develop a graft-vs… Expand
  • figure 1
  • figure 2
  • table I
  • table II
  • table III
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE